Royal Bank of Canada’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.2M | Buy |
510,065
+18,452
| +4% | +$2.3M | 0.01% | 800 |
|
|
2025
Q4 | $59.9M | Buy |
491,613
+49,118
| +11% | +$5.63M | 0.01% | 859 |
|
|
2025
Q3 | $44.3M | Sell |
442,495
-10,907
| -2% | -$982K | 0.01% | 1084 |
|
|
2025
Q2 | $37.6M | Buy |
453,402
+61,986
| +16% | +$4.95M | 0.01% | 1104 |
|
|
2025
Q1 | $31.7M | Sell |
391,416
-101,176
| -21% | -$9.04M | 0.01% | 1020 |
|
|
2024
Q4 | $44.4M | Sell |
492,592
-453,293
| -48% | -$43.9M | 0.01% | 891 |
|
|
2024
Q3 | $93.5M | Sell |
945,885
-73,434
| -7% | -$7.21M | 0.02% | 575 |
|
|
2024
Q2 | $94.5M | Sell |
1,019,319
-59,142
| -5% | -$5.3M | 0.02% | 536 |
|
|
2024
Q1 | $102M | Buy |
1,078,461
+349,519
| +48% | +$32.4M | 0.02% | 514 |
|
|
2023
Q4 | $65.1M | Sell |
728,942
-32,825
| -4% | -$2.44M | 0.02% | 672 |
|
|
2023
Q3 | $55.6M | Buy |
761,767
+176,631
| +30% | +$14.1M | 0.02% | 655 |
|
|
2023
Q2 | $48.7M | Sell |
585,136
-23,549
| -4% | -$1.97M | 0.01% | 710 |
|
|
2023
Q1 | $46.4M | Sell |
608,685
-34,171
| -5% | -$2.84M | 0.01% | 710 |
|
|
2022
Q4 | $53.4M | Sell |
642,856
-11,892
| -2% | -$963K | 0.02% | 660 |
|
|
2022
Q3 | $51.9M | Buy |
654,748
+134,852
| +26% | +$11.4M | 0.02% | 621 |
|
|
2022
Q2 | $38.6M | Sell |
519,896
-97,501
| -16% | -$7.32M | 0.01% | 767 |
|
|
2022
Q1 | $55.5M | Buy |
617,397
+65,463
| +12% | +$6.05M | 0.01% | 699 |
|
|
2021
Q4 | $61.8M | Buy |
551,934
+135,797
| +33% | +$16.4M | 0.01% | 725 |
|
|
2021
Q3 | $52.3M | Buy |
416,137
+47,516
| +13% | +$6.12M | 0.01% | 721 |
|
|
2021
Q2 | $49.9M | Buy |
368,621
+8,870
| +2% | +$1.17M | 0.01% | 759 |
|
|
2021
Q1 | $48.8M | Sell |
359,751
-46,579
| -11% | -$6.97M | 0.01% | 723 |
|
|
2020
Q4 | $57.2M | Sell |
406,330
-335,362
| -45% | -$43M | 0.02% | 650 |
|
|
2020
Q3 | $82.6M | Sell |
741,692
-34,834
| -4% | -$3.91M | 0.03% | 444 |
|
|
2020
Q2 | $86.9M | Sell |
776,526
-57,029
| -7% | -$5.62M | 0.03% | 403 |
|
|
2020
Q1 | $64.6M | Buy |
833,555
+354,685
| +74% | +$31.4M | 0.03% | 424 |
|
|
2019
Q4 | $45.5M | Sell |
478,870
-375,340
| -44% | -$32.5M | 0.02% | 674 |
|
|
2019
Q3 | $65.1M | Buy |
854,210
+107,891
| +14% | +$8.97M | 0.03% | 496 |
|
|
2019
Q2 | $65.5M | Buy |
746,319
+250,476
| +51% | +$21.4M | 0.03% | 483 |
|
|
2019
Q1 | $44.9M | Sell |
495,843
-134,332
| -21% | -$11.4M | 0.02% | 617 |
|
|
2018
Q4 | $45.2M | Buy |
630,175
+6,465
| +1% | +$521K | 0.02% | 559 |
|
|
2018
Q3 | $59.8M | Buy |
623,710
+65,143
| +12% | +$6.32M | 0.02% | 513 |
|
|
2018
Q2 | $53.2M | Sell |
558,567
-9,413
| -2% | -$865K | 0.02% | 535 |
|
|
2018
Q1 | $49.8M | Buy |
567,980
+134,293
| +31% | +$12.3M | 0.02% | 589 |
|
|
2017
Q4 | $36.8M | Sell |
433,687
-37,306
| -8% | -$3.13M | 0.02% | 765 |
|
|
2017
Q3 | $40.8M | Sell |
470,993
-7,187
| -2% | -$576K | 0.02% | 665 |
|
|
2017
Q2 | $36.9M | Buy |
478,180
+130,273
| +37% | +$9.24M | 0.02% | 682 |
|
|
2017
Q1 | $24.1M | Sell |
347,907
-78,043
| -18% | -$5.24M | 0.01% | 909 |
|
|
2016
Q4 | $25.2M | Sell |
425,950
-35,164
| -8% | -$2.17M | 0.01% | 897 |
|
|
2016
Q3 | $30.6M | Sell |
461,114
-10,885
| -2% | -$673K | 0.02% | 743 |
|
|
2016
Q2 | $25.5M | Buy |
471,999
+177,607
| +60% | +$9.73M | 0.02% | 793 |
|
|
2016
Q1 | $15.2M | Sell |
294,392
-34,984
| -11% | -$1.82M | 0.01% | 1113 |
|
|
2015
Q4 | $23.1M | Buy |
329,376
+213,536
| +184% | +$14.6M | 0.02% | 860 |
|
|
2015
Q3 | $7.21M | Sell |
115,840
-274,610
| -70% | -$21.6M | 0.01% | 1359 |
|
|
2015
Q2 | $32.8M | Buy |
390,450
+10,107
| +3% | +$786K | 0.02% | 567 |
|
|
2015
Q1 | $28.6M | Buy |
380,343
+322,794
| +561% | +$22.5M | 0.02% | 632 |
|
|
2014
Q4 | $3.58M | Sell |
57,549
-11,181
| -16% | -$637K | ﹤0.01% | 1875 |
|
|
2014
Q3 | $3.57M | Buy |
68,730
+12,057
| +21% | +$615K | ﹤0.01% | 1872 |
|
|
2014
Q2 | $2.91M | Sell |
56,673
-14,880
| -21% | -$671K | ﹤0.01% | 2022 |
|
|
2014
Q1 | $3.4M | Buy |
71,553
+13,230
| +23% | +$677K | ﹤0.01% | 1858 |
|
|
2013
Q4 | $2.53M | Sell |
58,323
-59,235
| -50% | -$2.45M | ﹤0.01% | 2116 |
|
|
2013
Q3 | $5.06M | Sell |
117,558
-45,939
| -28% | -$1.86M | ﹤0.01% | 1581 |
|
|
2013
Q2 | $5.68M | Buy |
+163,497
| New | +$5.75M | ﹤0.01% | 1372 |
|
Other funds holding XBI
Royal Bank of Canada's XBI Position: Q1 2026 in Review
Royal Bank of Canada increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.8% in Q1 2026, buying an estimated $2.3M and bringing the position to 510,065 shares worth $65.2M. The position accounts for 0.01% of the portfolio, ranked #800.
Royal Bank of Canada first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $102M in Q1 2024. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Royal Bank of Canada held 510,065 shares of State Street SPDR S&P Biotech ETF worth $65.2M as of Q1 2026.
- Royal Bank of Canada bought 18,452 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $2.3M.
- State Street SPDR S&P Biotech ETF made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #800 holding.
- Royal Bank of Canada first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's State Street SPDR S&P Biotech ETF position peaked at $102M in Q1 2024.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.